Rechercher des projets européens

21 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Geometric analysis in the Euclidean space (ANGEOM)

Date du début: 1 mai 2013, Date de fin: 30 avr. 2018,

"We propose to study different questions in the area of the so called geometric analysis. Most of the topics we are interested in deal with the connection between the behavior of singular integrals and the geometry of sets and measures. The study of this connection has been shown to be extremely helpful in the solution of certain long standing problems in the last years, such as the solution of th ...
Voir le projet

 1

 TERMINÉ 

Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action (EUROFANCOLEN)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,

Fanconi anemia (FA) is a rare inherited syndrome characterized by the early development of bone marrow failure and increasing predisposition to cancer with age. Allogeneic hematopoietic cell transplantation (alloHCT) is the only curative therapy for hematopoietic manifestations of FA, although associated with complications arising from myeloablation, graft versus host disease and increased inciden ...
Voir le projet

 13

 TERMINÉ 

NEurocontrolled BIdirectional Artificial upper limb and hand prosthesiS (NEBIAS)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,

The NEBIAS ("NEurocontrolled BIdirectional Artificial upper limb and hand prosthesiS") proposal aims at developing and clinically evaluating (in selected amputees) a neuro-controlled upper limb prosthesis intuitively controlled and felt by the amputee as the natural one. This will be possible by means of a novel neural interface able to provide a stable and very selective connection with the nervo ...
Voir le projet

 6

 TERMINÉ 

Advances in Small Trials dEsign for Regulatory Innovation and eXcellence (ASTERIX)

Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,

"ASTERIX will contribute towards the expected impact listed in the work program by delivering validated innovative statistical design methodologies for cost efficient clinical trials deriving reliable results from trials in small population groups, especially focusing on rare diseases. It directly addresses the rights of the estimated 30 million European patients suffering from rare diseases to th ...
Voir le projet

 7

 TERMINÉ 

Targeted disease prophylaxis in European fish farming (TargetFish)

Date du début: 1 oct. 2012, Date de fin: 30 sept. 2017,

European aquaculture production provides direct employment to 65.000 people with a turnover of 3 billion €. However, the lack of authorised veterinary medicinal products and the consequent disease outbreaks in farmed fish species costs the sector 20% of the production value. The most appropriate method for disease control, both on economical and ethical grounds, is disease prevention by vaccinatio ...
Voir le projet

 32

 TERMINÉ 

Natural sensory feedback for phantom limb pain modulation and therapy (EPIONE)

Date du début: 1 sept. 2013, Date de fin: 31 août 2017,

"Amputation of a limb may result from trauma or surgical intervention. The amputation traumatically alters the body image, but often leaves sensations that refer to the missing body part. In 50-80% amputees, neuropathic pain develops, also called phantom limb pain (PLP). Both peripheral and central nervous system factors have been implicated as determinants of PLP. Also, PLP may be triggered by ph ...
Voir le projet

 13

 TERMINÉ 

Open Project for the European Radiation Research Area (OPERRA)

Date du début: 1 juin 2013, Date de fin: 31 mai 2017,

"Within the OPERRA project, it is proposed that the MELODI Association, as a well-advanced network, takes the lead in establishing the necessary structures able to manage the long-term European research programmes in radiation protection, also taking advantage of the valuable experience gathered through the DoReMi network of excellence. Whilst in fields adjacent to low-dose risk research (radioeco ...
Voir le projet

 71

 TERMINÉ 

A common European approach to the regulatory testing of nanomaterials (NANOREG)

Date du début: 1 mars 2013, Date de fin: 28 févr. 2017,

The innovative and economic potential of Manufactured Nano Materials (MNMs) is threatened by a limited understanding of the related EHS issues. While toxicity data is continuously becoming available, the relevance to regulators is often unclear or unproven. The shrinking time to market of new MNM drives the need for urgent action by regulators. NANoREG is the first FP7 project to deliver the answe ...
Voir le projet

 73

 TERMINÉ 

Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation (INFRAFRONTIER-I3)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,

The mouse shows great similarities in development, physiology and biochemistry to humans, which makes it a key model for research into human disease. The major challenges for mouse functional genomics in the 21st century are to:• Develop a series of mutant alleles for every gene in the mouse genome• Determine the phenotypic consequences of each mutation• Identify mouse models for the complete dise ...
Voir le projet

 24

 TERMINÉ 

Enabling the drying process to save energy and water, realising process efficiency in the dairy chain (ENTHALPY)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2016,

Saving energy and water in the Dairy industry, by introducing innovations in the processing plant. Namely RF heating, solar thermal energy, mono-disperse atomising, dryer modelling, inline monitoring, cleaning with enzymes and membrane technology. With these technologies energy and water loops are closed instead of lost in the plant. These technologies will be demonstrated in pilot facilities.The ...
Voir le projet

 19

 TERMINÉ 

Studies on a cohort of Serbian children exposed to x-irradiation to determine the contribution of the non-coding genome to susceptibility at low doses (DARK.RISK)

Date du début: 1 oct. 2012, Date de fin: 31 mars 2016,

"The epidemiological study of Tinea capitis (ringworm) patients has proven useful for the study of carcinogenic effects of low dose radiation. In Dark.risk we will develop a new epidemiological cohort based upon the 24 000 cases irradiated in childhood that we will document to create the Serbian Registry of Tinaea Capitis Children (SRTCC). Unlike many other epidemiological cohorts SRTCC can be use ...
Voir le projet

 5

 TERMINÉ 

Magnetic Nano Actuators for Quantitative Analysis (MANAQA)

Date du début: 1 août 2012, Date de fin: 31 janv. 2016,

The MANAQA project is a multidisciplinary approach that combines innovative technologies emerging from different fields including nanotechnology, biochemistry, and nanorobotics. The strategy that will be exploited is based on a recently developed 5-DOF magnetic manipulation system combined with an atomic force microscope (AFM) system and functionalized magnetic nanowires. The fusion of these techn ...
Voir le projet

 6

 TERMINÉ 

Realizing the European Network in Biodosimetry (RENEB)

Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,

Creating a sustainable network in biological dosimetry that involves a large number of experienced laboratories throughout the EU will significantly improve the accident and emergency response capabilities in case of a large-scale radiological emergency. A well organised cooperated action involving EU laboratories will offer the only chance for a fast and trustworthy dose assessment urgently neede ...
Voir le projet

 28

 TERMINÉ 

"A new integrative framework for the study of fish welfare based on the concepts of allostasis, appraisal and coping styles" (COPEWELL)

Date du début: 1 juil. 2011, Date de fin: 31 déc. 2015,

"COPEWELL aims to provide a better understanding of the underpinning mechanisms and basic knowledge about the physiology, biology, and behaviour of fishes and to give a deeper understanding of the basic mechanisms involved in coping styles. We will use an innovative hypothesis-driven multidisciplinary approach that aims to explore the links between brain function, behaviour and adaptive plastici ...
Voir le projet

 18

 TERMINÉ 

Evolutionary and functional analysis of polymorphic inversions in the human genome (INVFEST)

Date du début: 1 févr. 2010, Date de fin: 31 oct. 2015,

"The last years have seen an extraordinary explosion of studies characterizing genome variation at different levels, and have opened new opportunities in deciphering the genetic basis of phenotypic characteristics and the evolutionary forces involved. One of the major breakthroughs has been the discovery of an unprecedented degree of structural variation in the human genome, including deletions, d ...
Voir le projet

 1

 TERMINÉ 

Biohybrid templates for peripheral nerve regeneration (Biohybrid)

Date du début: 1 oct. 2011, Date de fin: 30 sept. 2015,

The BIOHYBRID consortium was build up with the overall aim to develop, in a preclinical perspective, an innovative biohybrid artificial nerve device for the regenerative treatment of traumatic injuries of peripheral nerves. This consortium consists of three active and well integrated SMEs as well as seven academic partners that are recognised leaders in the scientific areas of interest for this pr ...
Voir le projet

 10

 TERMINÉ 

A novel high-throughput tool to genotype human genome inversions for personalised medicine (INGENIHUS)

Date du début: 1 juin 2014, Date de fin: 31 mai 2015,

The completion of the Human Genome Project has generated a new industry of personal genomics and personalized medicine, which aims to determine the entire DNA sequence of an individual to predict possible disease risks and improve treatment. However, despite the initial high expectations, it has not been possible to find the genetic causes for many common and complex diseases. Most of the work has ...
Voir le projet

 1

 TERMINÉ 

Micro and Nano Engineered Bi-Directional Carbon Interfaces for Advanced Peripheral Nervous System Prosthetics and Hybrid Bionics (MERIDIAN)

Date du début: 1 mars 2012, Date de fin: 28 févr. 2015,

The main goal of this proposal is to bring novel technology of biocompatible, low bio-fouling, high electrochemical performance carbon nanomaterials to in-vivo preclinical applications and at the same time to use this materials to develop a highly advanced concept of intimate intracellular contact, based on bottom - up technology of, engulfing the micro-electrode by neural cells. Such bionic inter ...
Voir le projet

 11

 TERMINÉ 

Transcription, summarisation and documentation of meetings using advanced speech technologies, indexing and browsing capabilities (DocuMeet)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2014,

Meetings are vital to all organisations, yet they are often not as effective as they could be. In SMEs, meeting outcomes and the ability to act upon them, are of particular importance and may have crucial impact on the future of the company. It is vital that SMEs have the adequate tools to exploit the knowledge and decisions generated in meetings. However, recording meeting minutes is expensive in ...
Voir le projet

 8

 TERMINÉ 

Coordinating the cooperation of the ESFRI project Infrafrontier with the International Phenotyping Consortium (IMPC) (INFRACOMP)

Date du début: 1 oct. 2011, Date de fin: 30 sept. 2014,

InfraCoMP will establish efficient coordination mechanisms between the ESFRI project Infrafrontier and the International Mouse Phenotyping Consortium. Infrafrontier is a pan-European initative to build a sustainable research infrastructure for systemic phenotyping, archiving and distribution of mouse models of human diseases. The IMPC is a global project to carry out systemic phenotyping of mouse ...
Voir le projet

 9

 TERMINÉ 

Pharmaceutical Medicine Training Programme (PHARMATRAIN)

Date du début: 1 mai 2009, Date de fin: 30 avr. 2014,

"The proposed Pharmaceutical Medicine Training Programme provides a comprehensive solution for the complex needs of integrated drug development for all professionals involved, incl. physicians, pharmaceutical scientists,biologists, biometricians, health economists, and safety and regulatory scientists from universities, regulatory agencies, large, middle-sized and small pharmaceutical enterprises, ...
Voir le projet

 52